New Zealand markets close in 9 minutes

Cano Health, Inc. (CANO)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
1.1200+0.0100 (+0.90%)
At close: 04:00PM EDT
1.1200 0.00 (0.00%)
After hours: 06:53PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 394.65M
Enterprise value 1.57B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.13
Price/book (mrq)1.55
Enterprise value/revenue 0.61
Enterprise value/EBITDA 98.15

Trading information

Stock price history

Beta (5Y monthly) 0.08
52-week change 3-83.16%
S&P500 52-week change 3-13.71%
52-week high 39.7500
52-week low 30.9800
50-day moving average 31.3958
200-day moving average 33.8124

Share statistics

Avg vol (3-month) 38.24M
Avg vol (10-day) 34.72M
Shares outstanding 5264.18M
Implied shares outstanding 6N/A
Float 8215.54M
% held by insiders 128.25%
% held by institutions 144.68%
Shares short (14 Mar 2023) 430.51M
Short ratio (14 Mar 2023) 43.79
Short % of float (14 Mar 2023) 417.78%
Short % of shares outstanding (14 Mar 2023) 411.55%
Shares short (prior month 14 Feb 2023) 426.14M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Dec 2022


Profit margin -7.57%
Operating margin (ttm)-2.86%

Management effectiveness

Return on assets (ttm)-2.41%
Return on equity (ttm)-66.27%

Income statement

Revenue (ttm)2.74B
Revenue per share (ttm)12.50
Quarterly revenue growth (yoy)38.20%
Gross profit (ttm)421.69M
Net income avi to common (ttm)-207.27M
Diluted EPS (ttm)-1.0400
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)27.33M
Total cash per share (mrq)0.1
Total debt (mrq)1.2B
Total debt/equity (mrq)242.72
Current ratio (mrq)1.63
Book value per share (mrq)1.13

Cash flow statement

Operating cash flow (ttm)-146.34M
Levered free cash flow (ttm)-117.43M